Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Prof Shafi Ahmed speaks to ecancer at CCLMIC 2019 about using technologies in low and middle income countries.
Initially, Prof Ahmed outlines some of the new exciting technologies that can be used in healthcare.
He takes VR as one example of these, and then some ways these can be put in oncological context.
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Best practice in HRRm testing in patients with metastatic prostate cancer
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Choosing Wisely in radiology Tanzania
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
Why tumour markers are not recommended as screening tests
War in Ukraine: The logistical challenges of transferring medical materials
Advancing breast cancer diagnosis in the developing world